Prostate Cancer - Results from #240

Accurate prostate cancer detection based on enrichment and characterization of prostate cancer specific circulating tumor cells. February 2, 2023

Estimating the Number of Men Living with Metastatic Prostate Cancer in the United States. February 1, 2023

Price transparency of prostate cancer care in the United States: An analysis of pricing and disclosure following the centers for medicare and medicaid mandate. February 1, 2023

Exercise Associated with Cognitive Function in Older Men with Prostate Cancer Undergoing Androgen Deprivation Therapy. February 1, 2023

Foreign accent syndrome as a heralding manifestation of transformation to small cell neuroendocrine prostate cancer. February 1, 2023

Randomised phase II trial of stereotactic body radiotherapy in combination with checkpoint inhibitors in metastatic castration-resistant prostate cancer (CheckPRO): a study protocol. February 1, 2023

Active surveillance in renal transplant patients with prostate cancer: a multicentre analysis. January 31, 2023

Prosteria - National Trends and Outcomes of More Frequent than Guideline Recommended Prostate Specific Antigen Screening. January 31, 2023

Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial. January 31, 2023

Treatment decision-making among patients with metastatic prostate cancer: Impact of decision locus of control on functional outcomes and decision satisfaction. January 31, 2023

Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer-A Report of a Movember International Consensus Meeting. January 31, 2023

WNT pathway mutations in metachronous oligometastatic castration-sensitive prostate cancer. January 31, 2023

Appropriateness and complications of androgen deprivation therapy for prostate cancer: Can we do better? A retrospective observational analysis from a referral center. January 30, 2023

Intermittent Hormonal Therapy in Biochemical Recurrence of Prostate Cancer Is Worth Considering Because of Mitigation of Cardiovascular Events and Reduction of Other Effects. January 30, 2023

Extended therapy with [177Lu]Lu-PSMA-617 in responding patients with high-volume metastatic castration-resistant prostate cancer. January 30, 2023

Choosing active surveillance versus curative treatment in a population-based survey of men with low-risk prostate cancer. January 30, 2023

Analytical dosimetric study of intensity-modulated radiotherapy (IMRT) and volumetric-modulated arc therapy (VMAT) for prostate cancer. January 30, 2023

Selecting a PRO-CTCAE-based subset for patient-reported symptom monitoring in prostate cancer patients: a modified Delphi procedure. January 30, 2023

Preliminary comparison of the modified extraperitoneal free-PORT single incision technique and transabdominal multi-incision robot-assisted laparoscopic radical prostatectomy. January 30, 2023

A role for laparoscopy in the age of robotics: a retrospective cohort study of perioperative outcomes between 2D laparoscopic radical prostatectomy vs 3DHD laparoscopic radical prostatectomy. January 30, 2023

Page 13 of 1288